Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
ACS Synth Biol. 2024 Sep 20;13(9):2693-2701. doi: 10.1021/acssynbio.4c00316. Epub 2024 Aug 27.
Deaminase-T7 RNA polymerase fusion (MutaT7) proteins are a growing class of synthetic biology tools used to diversify target genes during laboratory evolution. To date, MutaT7 chimeras comprise either a deoxyadenosine or deoxycytidine deaminase fused to a T7 RNA polymerase. Their expression drives targeted deoxyadenosine-to-deoxyguanosine or deoxycytidine-to-deoxythymidine mutagenesis, respectively. Here, we repurpose recently engineered substrate-promiscuous general deaminases (GDEs) to establish a substantially simplified system based on a single chimeric enzyme capable of targeting both deoxyadenosine and deoxycytidine. We assess on- and off-target mutagenesis, strand and context preference, and parity of deamination for four different MutaT7 constructs. We identify a single chimera that installs all possible transition mutations more efficiently than preexisting, more cumbersome MutaT7 tools. The optimized MutaT7 chimera reported herein is a next-generation hypermutator capable of mediating efficient and uniform target-gene diversification during directed evolution.
脱氨酶-T7 RNA 聚合酶融合(MutaT7)蛋白是一类新兴的合成生物学工具,用于在实验室进化过程中多样化目标基因。迄今为止,MutaT7 嵌合体由脱氧腺苷或脱氧胞苷脱氨酶与 T7 RNA 聚合酶融合而成。它们的表达分别导致靶向脱氧腺嘌呤到脱氧鸟嘌呤或脱氧胞嘧啶到脱氧胸苷的突变。在这里,我们重新设计了最近工程化的底物广谱通用脱氨酶(GDEs),建立了一个基于单个嵌合酶的简化系统,该酶能够靶向脱氧腺嘌呤和脱氧胞嘧啶。我们评估了四种不同 MutaT7 构建体的靶内和靶外突变、链和上下文偏好以及脱氨的奇偶性。我们确定了一种单一的嵌合体,它比以前更复杂的 MutaT7 工具更有效地安装所有可能的转换突变。本文报道的优化 MutaT7 嵌合体是一种下一代超突变体,能够在定向进化过程中有效地和均匀地进行靶基因多样化。